K-Medi Hub (Daegu-Gyeongbuk Advanced Medical Industry Promotion Foundation, Chairman Yang Jin-young) announced on the 26th that it had signed a business agreement with enParticle Co., Ltd. on the 22nd for the development of new drugs. According to the agreement, the two institutions will conduct joint research on microfluidic technology and mass production technology for pharmaceuticals. Chairman Yang Jin-young said, “As the global microfluidics market develops day by day, joint development of microfluidic technology will contribute to vitalizing the domestic pharmaceutical industry.” Chairman Yang Jin-young (third from left in front row) and Ko Jeong-sang (third from right in front row), CEO of enParticle, are taking a commemorative photo with officials from both sides after a business agreement. [Photo = KMediHub]
Source: Medi Consumer News (http://www.medisobizanews.com)
